Add an ACE Inhibitor or ARB as the Third Agent
For this 68-year-old woman already on maximum-dose diltiazem (a calcium channel blocker) and hydrochlorothiazide (a thiazide diuretic), the next medication to add should be an ACE inhibitor (such as lisinopril or ramipril) or an angiotensin receptor blocker (ARB, such as losartan or telmisartan). This represents the standard three-drug combination recommended by multiple international guidelines for resistant hypertension 1.
Rationale for ACE Inhibitor or ARB Addition
The most recent and comprehensive guidelines consistently recommend a specific three-drug combination for uncontrolled hypertension: a calcium channel blocker + thiazide/thiazide-like diuretic + renin-angiotensin system (RAS) blocker 1, 2. Since your patient already has the first two components (diltiazem and hydrochlorothiazide), adding the third component—an ACE inhibitor or ARB—completes this evidence-based regimen.
The 2020 International Society of Hypertension guidelines explicitly state that when blood pressure remains uncontrolled on two drugs, the next step is to add a third agent from a different class, with the preferred three-drug combination being "a RAS blocker with a dihydropyridine CCB and a thiazide/thiazide-like diuretic" 1. While diltiazem is a non-dihydropyridine CCB (rather than a dihydropyridine like amlodipine), the principle of combining these three complementary mechanisms remains valid.
Specific Drug Choices
ACE Inhibitor options:
- Lisinopril 10-40 mg daily
- Ramipril 2.5-10 mg daily
- Enalapril 5-40 mg daily
ARB options (if ACE inhibitor causes cough):
- Losartan 50-100 mg daily
- Telmisartan 40-80 mg daily
- Valsartan 80-320 mg daily
Start with low doses and titrate upward based on blood pressure response and tolerability 3, 4.
Why This Combination Works
These three drug classes have complementary mechanisms of action that produce additive blood pressure lowering 3, 5:
- Diltiazem (CCB): Causes vasodilation by blocking calcium channels in vascular smooth muscle
- Hydrochlorothiazide (thiazide diuretic): Reduces blood volume and causes vasodilation
- ACE inhibitor/ARB: Blocks the renin-angiotensin system, reducing vasoconstriction and aldosterone secretion
The combination also has metabolic benefits: the RAS blocker helps counteract the potassium-wasting effects of hydrochlorothiazide and may reduce the risk of new-onset diabetes associated with thiazide diuretics 6, 7.
Important Considerations for This 68-Year-Old Patient
Age-related factors:
- The 2020 Hypertension Canada guidelines recommend individualizing blood pressure targets in elderly patients based on frailty 4
- For non-frail elderly patients, standard targets apply (systolic BP <140 mmHg), but the 2024 ESC guidelines suggest targeting 120-129 mmHg systolic if well-tolerated 2
- Monitor for orthostatic hypotension when adding the third agent, especially in elderly patients 8
Monitoring requirements:
- Check serum creatinine and potassium 1-2 weeks after starting an ACE inhibitor or ARB 9
- Monitor blood pressure every 2-4 weeks until controlled 3, 5
- Watch for ACE inhibitor-related cough (occurs in 5-20% of patients); if this develops, switch to an ARB
Critical Pitfall to Avoid
Never combine an ACE inhibitor with an ARB 3, 10, 11, 4, 8. This combination is explicitly contraindicated due to increased risk of hyperkalemia, hypotension, and acute kidney injury without additional cardiovascular benefit 8. Choose one or the other, not both.
If Blood Pressure Remains Uncontrolled
If blood pressure is still not controlled after optimizing this three-drug regimen, the fourth-line agent should be spironolactone 25-50 mg daily (a mineralocorticoid receptor antagonist), which is the most effective fourth-line agent for resistant hypertension 1. Alternative fourth-line options if spironolactone is contraindicated include amiloride, doxazosin, eplerenone, clonidine, or a beta-blocker 1.
Consider Medication Adherence and Secondary Causes
Before adding medications, verify that the patient is actually taking her current medications as prescribed 1. The guidelines emphasize checking adherence as a key step in managing apparent treatment resistance 3, 11. Also consider whether secondary causes of hypertension (such as primary aldosteronism, renal artery stenosis, or obstructive sleep apnea) should be evaluated, particularly given that she requires three medications 1.